You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-CD24 antibody [8.B.76]See all CD24 primary antibodies ...
  • Description
    Mouse monoclonal [8.B.76] to CD24
  • Tested applicationsICC, Flow Cyt, IHC-Fr, IHC-P more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Human bone marrow malignant cells from a non-B, non-T acute leukemia. MW: 35-45kD.

  • General notesCD24 expression can also be observed in the cytoplasm.

Properties

Applications

Our Abpromise guarantee covers the use of ab31622 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
ICC ICC: 1/25 - 1/50. Cell smear.
Flow Cyt Flow Cyt: Use 2µg for 105 cells.
IHC-Fr IHC-Fr: 1/25 - 1/50.
IHC-P IHC-P: Use at an assay dependent dilution.

Target

  • FunctionModulates B-cell activation responses. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells.
  • Tissue specificityB-cells. Expressed in a number of B-cell lines including P32/SH and Namalwa. Expressed in erythroleukemia cell and small cell lung carcinoma cell lines. Also expressed on the surface of T-cells.
  • Involvement in diseaseGenetic variations in CD24 are associated with susceptibility to multiple sclerosis (MS) [MIM:126200]. A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheat, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. Note=Polymorphisms in CD24 may act as a genetic modifier for susceptibility and progression of MS in some populations, perhaps by affecting the efficiency of CD24 expression on the cell surface.
  • Sequence similaritiesBelongs to the CD24 family.
  • Post-translational
    modifications
    Extensively O-glycosylated.
  • Cellular localizationCell membrane.
  • Target information above from: UniProt accession P25063 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      CD 24 antibodyCD24 antibodyCD24 antigen (small cell lung carcinoma cluster 4 antigen) antibody
      CD24 antigen antibodyCD24 molecule antibodyCD24_HUMAN antibodyCD24A antibodyFLJ22950 antibodyFLJ43543 antibodyGPI linked surface mucin antibodyGPI linked surface mucin antibodyHeat stable antigen antibodyHSA antibodyMGC75043 antibodyNectadrin antibodySignal transducer CD24 antibodySmall cell lung carcinoma cluster 4 antigen antibody
    see all

Anti-CD24 antibody [8.B.76] images

  • ab31622 staining CD24 in human colon tissue sections by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections). Tissue was fixed with formaldehyde, then a heat mediated antigen retrieval step was performed using citrate buffer pH 6 (20 minutes). Samples were then incubated with the primary antibody at a 1/100 dilution for 16 minutes at 25°C. An undiluted HRP-conjugated goat anti-mouse/rabbit monoclonal was used as secondary antibody.

    See Abreview

References for Anti-CD24 antibody [8.B.76] (ab31622)

This product has been referenced in:
  • Rasmussen JG  et al. Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1. PLoS One 7:e46087 (2012). Flow Cyt ; Human . Read more (PubMed: 23049945) »
  • Metsuyanim S  et al. Expression of stem cell markers in the human fetal kidney. PLoS One 4:e6709 (2009). IHC-P ; Human . Read more (PubMed: 19696931) »

See all 2 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (colon, normal and cancer)
Specification colon, normal and cancer
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: citrate buffer pH6, 20 min
Permeabilization No
Username

Verified customer

Submitted May 11 2010

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"